Articles

Oral strategies to target proprotein convertase subtilisin/kexin type 9 and lipoprotein(a): the new frontier of lipid lowering

Norata GD, Tokgözoğlu L

Journal: 

Eur Heart J

First published: November 8, 2023  DOI: 10.1093/eurheartj/ehad682